drugset / Trial / NCT05334017

Xylometazoline and Cocaine for Nasal Vasoconstriction

NCT05334017

Phase 4 Completed 120 enrolled Rigshospitalet, Denmark
RandomizedParallel-groupTriple-blindPrevention

Summary

The objective of this study is to compare xylometazoline and cocaine's effect on minimizing epistaxis when administered as a local vasoconstrictor prior to nasal intubation. The investigators hypothesize that there will be a lower bleeding score in the group receiving xylometazoline as compared with the group receiving cocaine.

Timeline

Start
2022-09-08
Primary completion
2023-03-21
Completion
2023-03-22

Drugs

EvaluationDrugModalityDoseRoute
Comparator Cocaine Small molecule 2 ml Intranasal
Comparator Cocaine Small molecule 4 % Intranasal
Comparator Xylometazoline Small molecule 0.1 % Intranasal
Comparator Xylometazoline Small molecule 1 ml Intranasal

Indications

No indication recorded.